24
Views
3
CrossRef citations to date
0
Altmetric
Health Outcomes

Dabigatran Etexilate: A Possible Replacement for Heparinoids and Vitamin K Antagonists?

, PharmD
Pages 105-125 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ryan Wilcox, Robert C. Pendleton, Kristi J. Smock & George M. Rodgers. (2011) Hospital-Based Clinical Implications of the Novel Oral Anticoagulant, Dabigatran Etexilate, in Daily Practice. Hospital Practice 39:3, pages 23-34.
Read now

Articles from other publishers (1)

Simon Michaelis, Anett Marais, Anna K. Schrey, Olivia Y. Graebner, Cornelia Schaudt, Michael Sefkow, Friedrich Kroll, Mathias Dreger, Mirko Glinski, Hubert Koester, Rainer Metternich & Jenny J. Fischer. (2012) Dabigatran and Dabigatran Ethyl Ester: Potent Inhibitors of Ribosyldihydronicotinamide Dehydrogenase (NQO2). Journal of Medicinal Chemistry 55:8, pages 3934-3944.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.